Total Payments
$291,399
2024 Payments
$43,181
Companies
8
Transactions
283
Payment Breakdown by Category
Other$233,664 (80.2%)
Travel$36,646 (12.6%)
Consulting$17,100 (5.9%)
Food & Beverage$3,968 (1.4%)
Education$20.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $176,077 | 74 | 60.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,588 | 24 | 19.8% |
| Travel and Lodging | $36,646 | 101 | 12.6% |
| Consulting Fee | $17,100 | 4 | 5.9% |
| Food and Beverage | $3,968 | 70 | 1.4% |
| Education | $20.68 | 10 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $150,759 | 135 | $0 (2023) |
| Horizon Pharma plc | $60,602 | 54 | $0 (2018) |
| Amgen Inc. | $43,181 | 33 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $36,601 | 48 | $0 (2019) |
| Leadiant Biosciences, Inc. | $212.00 | 2 | $0 (2022) |
| Azurity Pharmaceuticals, Inc. | $24.24 | 1 | $0 (2020) |
| Travere Therapeutics, Inc. | $15.00 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,181 | 33 | Amgen Inc. ($43,181) |
| 2023 | $50,622 | 50 | Horizon Therapeutics plc ($50,622) |
| 2022 | $26,467 | 31 | Horizon Therapeutics plc ($26,255) |
| 2021 | $21,882 | 20 | Horizon Therapeutics plc ($21,875) |
| 2020 | $24,468 | 20 | Horizon Therapeutics plc ($24,436) |
| 2019 | $34,913 | 30 | Horizon Therapeutics plc ($27,572) |
| 2018 | $31,598 | 34 | Horizon Pharma plc ($24,614) |
| 2017 | $58,269 | 65 | Horizon Pharma plc ($35,988) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/27/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/22/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| 09/24/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/07/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/07/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/07/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Consulting Fee | Cash or cash equivalent | $4,750.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $215.79 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/20/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $460.96 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/20/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $350.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/20/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/20/2024 | Amgen Inc. | PROCYSBI (Biological) | Food and Beverage | In-kind items and services | $121.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/13/2024 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $88.44 | General |
| 05/16/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,612.50 | General |
| 05/16/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| 05/08/2024 | Amgen Inc. | PROCYSBI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/03/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $1,107.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/03/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $348.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/03/2024 | Amgen Inc. | PROCYSBI (Biological) | Travel and Lodging | In-kind items and services | $262.26 | General |
| Category: Inflammation/Rare Disease | ||||||
About Dr. Mark Benfield, MD
Dr. Mark Benfield, MD is a Pediatric Nephrology healthcare provider based in Cullman, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811004245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Benfield, MD has received a total of $291,399 in payments from pharmaceutical and medical device companies, with $43,181 received in 2024. These payments were reported across 283 transactions from 8 companies. The most common payment nature is "Honoraria" ($176,077).
Ad
Practice Information
- Specialty Pediatric Nephrology
- Location Cullman, AL
- Active Since 08/23/2006
- Last Updated 05/21/2025
- Taxonomy Code 2080P0210X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811004245
Products in Payments
- PROCYSBI (Drug) $211,360
- ACTHAR (Biological) $36,601
- PROCYSBI (Biological) $35,730
- Cystaran (Drug) $212.00
- Epaned (Drug) $24.24
- (815) Thiola (Drug) $13.32
- Thiola (Drug) $7.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.